Antitumor carbazoles

Anti-Cancer Agents in Medicinal Chemistry

Volumn 7, Issue 2, 2007, Pages 247-267

  Asche, Christian ^a   Demeunynck, Martine ^a  

^a UNIVERSITÉ JOSEPH FOURIER   (France)

Author keywords

Antitumor agents; DNA binder; DNA intercalation; Nitrogen heterocycles; Topoisomerase inhibition

Indexed keywords

2 (1H IMIDAZOL 4 YLMETHYL) 9H CARBAZOLE; 6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; 9 HYDROXYELLIPTICINE; ACRONINE; AMONAFIDE; AMSACRINE; ANTINEOPLASTIC AGENT; AZATOXIN; CARBAZOLE DERIVATIVE; DATELLIPTIUM CHLORIDE; DITERCALINIUM; DOXORUBICIN; EDOTECARIN; ELLIPTICINE; ELLIPTICINE DERIVATIVE; ELLIPTINIUM; ELLIPTINIUM ACETATE; ETOPOSIDE; GI 111924; KETOCONAZOLE; MITOMYCIN C; N (2 DIMETHYLAMINOETHYL) 9 HYDROXY 5,6 DIMETHYL 6H PYRIDO[4,3 B]CARBAZOLE 1 CARBOXAMIDE; OLIVACINE; PAZELLIPTINE; PIBENZIMOL; PYRIDO[4,3 B]CARBAZOLE DERIVATIVE; REBECCAMYCIN; STAUROSPORINE; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; BLOOD TOXICITY; BREAST CANCER; CANCER RESISTANCE; CLINICAL TRIAL; CYTOTOXICITY; DRUG DNA INTERACTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; INTERCALATION COMPLEX; LEUKEMIA; LIVER DYSFUNCTION; LIVER TOXICITY; MULTIDRUG RESISTANCE; NAUSEA; NONHUMAN; PROSTATE CANCER; REVIEW; SINGLE DRUG DOSE; SOLID TUMOR; STRUCTURE ACTIVITY RELATION; UNSPECIFIED SIDE EFFECT; VOMITING;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBAZOLES; DNA, NEOPLASM; HUMANS; INTERCALATING AGENTS;

CYTOTOXICITY; DNA; ELECTROPOLYMERIZATION; ENZYMES; MEDICAL APPLICATIONS; POLYCYCLIC AROMATIC HYDROCARBONS;

ANTI-TUMOR AGENTS; CARBAZOLE DERIVATIVES; CLINICAL APPLICATION; CYCLIN-DEPENDENT KINASE; DNA INTERCALATIONS; MULTIDRUG RESISTANCE; NITROGEN HETEROCYCLES; TOPOISOMERASE INHIBITIONS;

ENZYME INHIBITION;

EID: 33947176009     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152007780058678     Document Type: Review

References (178)

1. Lerman, L.S. J. Mol. Biol. 1961, 3, 18.
2. Sobell, H.M. Nucleic Acid Geometry and Dynamics, Ramaswamy H. Sarma, Ed.; Pergamon Press: New York, 1980, pp. 289-323.
3. Demeunynck, M. Exp. Opin. Ther. Patents 2004, 14, 1.
4. Braña, M.F.; Cacho, M.; Cardillas, A.; de Pascual-Teresa, B.; Ramos, A. Curr. Pharm. Des. 2001, 7, 1745.
5. Martinez, R.; Chacón-Garcia, L. Curr. Med. Chem. 2005, 12, 1345.
6. Harley, C.B.; Futcher, A.B.; Greider, C.W. Nature 1990, 345, 458.
7. Lackburn, E.H. Nature 1991, 350, 569.
8. Sandell, L.L.; Zakian, V.A. Cell 1993, 75, 729.
9. Riou, J.-F. Curr. Med. Chem. 2002, 2, 567.
10. Chang, C.C.; Wu, J.Y.; Chang, T.C. J. Chin. Chem. Soc. 2003, 50, 185.
11. Chang, C.C.; Wu, J.Y.; Chien, C.W.; Wu, W.S.; Lu, H.; Kang, C.C.; Yu, L.J.; Chang, T.C. Anal. Chem. 2003, 75, 6177.
12. Chang, C.C.; Kuo, I.C.; Lin, J.J.; Lu, Y.C.; Chen, C.T.; Back, H.T.; Lou, P.J.; Chang, T.C. Chem. Biodiversity 2004, 1, 1377.
13. Kraut, E.H.; Fleming, T.; Segal, M.; Neidhart, J.A.; Behrens, B.C.; MacDonald, J. Invest. New Drugs 1991, 9, 95.
14. Mann, J.; Baron, A.; Opoku-Boahen, Y.; Johansson, E.; Parkinson, G.; Kelland, L.R.; Neidle, S. J. Med. Chem. 2001, 44, 138.
15. Jacquemard, U.; Routier, S.; Tatibouët, A.; Kluza, J.; Laine, W.; Bal, C.; Bailly, C.; Mérour, J.-Y. Org. Biomol. Chem. 2004, 2, 1476.
16. Dias, N.; Jacquemard, U.; Baldeyrou, B.; Tardy, C.; Lansiaux, A.; Colson, P.; Tanious, F.; Wilson, W.D.; Routier, S.; Mérour, J.-Y.; Bailly, C. Biochemistry 2004, 43, 15169.
17. Tanious, A.; Ding, D.; Patrick, D.A.; Bailly, C.; Tidwell, R.R.; Wilson, W.D. Biochemistry 2000, 39, 12091.
18. Tanious, F.A.; Wilson, W.D.; Patrick, D.A.; Tidwell, R.R.; Colson, P.; Houssier, C.; Tardy, C.; Bailly, C. Eur. J. Biochem. 2001, 268, 3455.
19. Crawford, E.D.; Eisenberger, M.A.; McLeod, D.G.; Spaulding, J.T.; Benson, R.; Dorr, F.A.; Blumenstein, B.A.; Davis, M.A.; Goodman, P.J. New Engl. J. Med. 1989, 321, 419.
20. Hall, P.F. J. Steroid. Biochem. Mol. Biol. 1991, 40, 527.
21. Miller, W.L. Endocr. Rev. 1988, 9, 295.
22. Yanase, T.; Simpson, E.R.; Waterman, M.R. Endocr. Rev. 1991, 12, 91.
23. Barrie, S.E.; Jarman, M. Endocr.-Relat. Cancer 1996, 3, 25.
24. Njar, V.C.; Brodie, A.M. Curr. Pharm. Des. 1999, 5, 163.
25. Leroux, F. Curr. Med. Chem. 2005, 12, 1623.
26. Trachtenberg, J.; Zadra, J. Clin. Invest. Med. 1988, 11, 1.
27. Williams, G.; Kerle, D.J.; Doble, A.; Dulop, H.; Smith, C.; Allen, J.; Yeo, T.; Blooms, S.R. Br. J. Urol. 1986, 58, 45.
28. Coster, R.D.; Wouters, W.; Bruynseels, J. J. Steroid Biochem. Mol. Biol. 1996, 56, 133.
29. Ideyama, Y.; Kudoh, M.; Tanimoto, K.; Susaki, Y.; Nanya, T.; Nakahara, T.; Ishikawa, H.; Yoden, T.; Okada, M.; Fujikura, T.; Akaza, H.; Shikama, H. Prostate 1998, 37, 10.
30. Cherry, P.C.; Cocker, J.D.; Searle, A.D. WO 94/27989 Chem. Abstr. 1995, 123, 83368.
31. Ideyama, Y.; Kudoh, M.; Tanimoto, K.; Susaki, Y.; Nanya, T.; Nakahara, T.; Ishikawa, H.; Fujikura, T.; Akaza, H.; Shikama, H. Jpn. J. Pharmacol. 1999, 79, 213.
32. Lee, C.Y.; Kuo, S.C.; Teng, C.M.; Huang, L.J. Chin. Parm. J. 2002, 32, 25.
33. Lee, C.Y.; Huang, L.J.; Wang, J.P.; Kuo, S.C. Chin. Pharm. J. 2002, 54, 35.
34. Tsao, L.T.; Lee, C.Y.; Huang, L.J.; Kuo, S.C.; Wang, J.P. Biochem. Pharmacol. 2002, 63, 1961.
35. Ho, F.M.; Lai, C.C.; Huang, L.J.; Kuo, T.S.; Chao, C.M.; Lin, W.W. Br. J. Pharmacol. 2004, 141, 1037.
36. Huang, J.; Li, X.; Hilf, R.; Bambara, R.A.; Muyan, M. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2005, 5, 379.
37. Hsu, M.J.; Chao, Y.; Chang, Y.H.; Ho, F.M.; Huang, L.J.; Huang, Y.L.; Luh, T.Y.; Chen, C.P.; Lin, W.W. Biochem. Pharmacol. 2005, 70, 102.
38. Goodwin, S.; Smith, A.F.; Horning, E.C. J. Am. Chem. Soc. 1959, 81, 1903.
39. Schmutz, J.; Hunziker, F. Pharm. Acta Helv. 1958, 33, 341.
40. Dalton, L.K.; Demerac, S.; Elmes, B.C.; Loder, J.W.; Swan, J.M.; Teitei, T. Aust. J. Chem. 1967, 20, 2715.
41. Mosher, C.W.; Crews, O.P.; Action, E.M., Goodman, L. J. Med. Chem. 1966, 9, 237.
42. Le Pecq, J.B.; Gosse, C.; Dat-Xuong, N.; Paoletti, C. C. R. Hebd. Seances Acad. Sci., Ser. D 1975, 281, 1365.
43. Ross, N.E. Biochem. Pharmacol. 1985, 34, 4191.
44. Brossi, A. In The Alkaloids, Gribble, G.W., ed.; Academic Press: New York, 1990, Vol. 39, pp. 239-352.
45. Auclair, C. Biochem. Pharmacol. 2001, 62, 1675.
46. Mathé, G.; Triana, K.; Pontiggia, P.; Blanquet, D.; Hallard, M.; Morette, C. Biomed & Pharmacother. 1998, 52, 391.
47. Auclair, C. Arch. Biochem. Biophys. 1987, 259, 1.
48. Garbett, N.C.; Graves, D.E. Curr. Med Chem. - Anti-Cancer Agents 2004, 4, 509.
49. Kohn, K.W.; Waring, M.J.; Glaubiger, D.; Friedman, C.A. Cancer Res. 1975, 35, 71.
50. Patel, N.; Bergman, J.; Gräslund, A. Eur. J. Biochem. 1991, 197, 507.
51. Gale, E.F.; Cundliffe, E.; Reynolds, P.E.; Richmond, M.H.; Waring, M.J. In: The molecular basis of antibiotic action, 2nd ed., Wiley, London, 1981.
52. Larue, L.; Rivalle, C.; Muzard, G.; Paoletti, C.; Bisagni, E.; Paoletti, J J. Med. Chem. 1988, 31, 1951.
53. Liu, L.F. Annu. Rev. Biochem. 1989, 58, 351.
54. Corbett, A.H.; Osterhoff, N. Chem. Res. Toxicol. 1993, 6, 585.
55. Holden, J.A. Curr. Med. Chem. - Anti-Cancer Agents 2001, 1, 1.
56. Tewey, K.M.; Chen, G.L.; Nelson, E.M.; Liu, L.F. J. Biol. Chem. 1984, 259, 9182.
57. Monnot, M.; Mauffret, O.; Simon, V.; Lescot, E.; Psaume, B.; Saucier, J.M.; Charra, M.; Belehradek, J.; Fermandjian, S. J. Biol. Chem. 1991, 25, 1820.
58. Fossé, P.; René, B.; Charra, M.; Paoletti, C.; Saucier, J.M. Mol. Pharmacol. 1992, 42, 590.
59. Froelich-Ammon, S.J.; Patchan, M.W.; Osheroff, N.; Thompson, R.B. J. Biol. Chem. 1995, 270, 14998.
60. Fossé, P.; Charra, M.; Paoletti, C., Saucier, J.M.; René, B. Bull. Canc. 1994, 81, 194.
61. Bernadou, J.; Meunier, B.; Meunier, G.; Auclair, C.; Paoletti, C. Proc. Natl. Acad. Sci. USA 1984, 81, 1297.
62. Pratviel, G.; Bernadou, J.; Paoletti, C.; Meunier, B.; Gillet, B.; Guittet, E.; Lallemand, J.Y. Biochem. Biophys. Res. Commun. 1985, 128, 1173.
63. Frei, E.; Bieler, C.A.; Arlt, V.M.; Wiessler, M.; Stiborová, M. Biochem. Pharmacol. 2002, 64, 289.
64. Stiborová, M.; Sejbal, J.; Bořek-Dohalská, L.; Aimová, D.; Poljaková, J.; Forsterová, K.; Rupertová, M.; Wiesner, J.; Hudeček, J.; Wiessler, M.; Frei, E. Cancer Res. 2004, 64, 8374.
65. Rekha, G.K.; Sladek, N.E. Cancer Chemother. Pharmacol. 1997, 40, 215.
66. Sureau, F.; Moreau, F.; Millot, J.M.; Manfait, M.; Allard, B.; Aubard, J.; Schwaller, M.A. Biophys. J. 1993, 65, 1767.
67. Schwaller, M.A.; Allard, B.; Lescot, E.; Moreau, F. J. Biol. Chem. 1995, 270, 22709.
68. Dupont, J.; Dodin, G.; Schwaller, M.A. Plant Sci. Lett. 1987, 54, 109.
69. Ohashi, M.; Sugikawa, E.; Nakanishi, N. Jpn. J. Cancer Res. 1995, 86, 819.
70. Sugikawa, E.; Hosoi, T.; Yazaki, N.; Nakanishi, N.; Ohashi, M. Anticancer Res. 1999, 19, 3099.
71. Peng, Y.; Li, C.; Chen, L.; Sebti, S.; Chen, J. Oncogene 2003, 22, 4478.
72. Bisagni, E.; Ngyuen, C.H. Tetrahedron 1986, 42, 2311.
73. Bisagni, E.; Ngyuen, C.H.; Pierré, A.; Pépin, O.; De Cointet, P.; Gros, P. J. Med. Chem. 1988, 31, 398.
74. Ngyuen, C.H.; Lhoste, J.M.; Lavelle, F.; Bissery, M.C.; Bisagni, E. J. Med. Chem. 1990, 33, 1519.
75. Pognan, F.;Saucier, J.M.; Paoletti, C.; Kaczmarek, L.; Nantka-Namirski, P.; Mordarski, M.; Peczynska-Czoch, W. Biochem. Pharmacol. 1992, 44, 2149.
76. Peczynska-Czoch, W.; Pognan, F.; Kaczmarek, L.; Boratynski, J. J. Med. Chem. 1994, 37, 3503.
77. Ngyuen, C.H.; Fan, E.; Riou, J.F.; Bissery, M.C.; Vrignaud, P.; Lavelle, F.; Bisagni, E. Anticancer Drug Des. 1995, 10, 277.
78. Devraj, R.; Cushman, M. Bioorg. Med. Chem. 1997, 7, 369.
79. Juret, P.; Heron, J.F.; Couette, J.E.; Delozier, T.; Le Talaer, J.Y. Cancer Treat. Rep. 1982, 66, 1909.
80. Meunier, G.; Meunier, B. J. Biol. Chem. 1985, 260, 10576.
81. Rouesse, J.; Spielmann, M.; Turpin, F.; Lechevalier, T.; Azab, M.; Mondesir, J.M. Eur. J. Cancer 1993, 29A, 856.
82. Vistica, D.T.; Kennedy, S.; Hursey, M.L.; Boyd, M.R. Biochem. Biophys. Res. Commun. 1994, 200, 1762.
83. Arguello, F.; Alexander, M.A.; Greene, J.F. Jr.; Stinson, S.F.; Jorden, J.L.; Smith, E.M.; Kalavar, N.T.; Alvord, W.G.; Klabansky, R.L.; Sausville, E.A. J. Cancer Res. Clin. Oncol. 1998, 124, 19.
84. Snyder, R.D; Mc Nulty, J.; Zairov, G.; Ewing, D.E.; Hendry, L.B. Mutat. Res. 2005, 578, 88.
85. Le Pecq, J.B.; Paoletti, C. Chem. Abstr. 1982, 96, 181489.
86. Mucci-LoRusso, P.; Polin L.; Biernat, L.A.; Valeriote, F.A.; Corbett, T.H. Invest. New Drugs 1990, 8, 253.
87. Osashi, M.; Oki, T. Expert Opin. Ther. Patents 1996, 6, 1285.
88. Rivalle, C.; Ducrocq, C.; Bisagni, E. J. Chem. Soc. Perkin Trans. 1 1979, 138.
89. Bisagni, E.; Ducrocq, C.; Rivalle, C.; Tambouri, P.; Wendling, F.; Chermann, J.C.; Montagnier, L. Chem. Abstr. 1978, 90, 87427.
90. Lidereau, R.; Chermann, J.C.; Gruest, J.; Montagnier, L.; Ducrocq, C.; Rivalle, C.; Bisagni, E. Bull. Cancer 1980, 67, 1.
91. Haider, N.; Jbara, R.; Khadami, F.; Wanko, R. Heterocycles, 1998, 48, 1609.
92. Haider, N.; Sotelo, E. Chem. Pharm. Bull. 2002, 50, 1479.
93. Jasztold-Horwoko, R.; Landras, C.; Pierre, A.; Atassi, G.; Guilbaud, N.; Kraus-Berthier, L.; Leonce, S.; Rolland, Y.; Prost, J.F.; Bisagni, E. J. Med. Chem. 1994, 37, 2445.
94. Guilbaud, N.; Kraus-Berthier, L.; Saint-Dizier, D.; Rouillon, M.H.; Jan, M.; Burbridge, M.F.; Visalli, M.; Bisagni, E.; Pierré, A.; Atassi, G. Cancer Chemother. Pharmacol. 1996, 38, 513.
95. Guilbaud, N.; Kraus-Berthier, L.; Saint-Dizier, D.; Rouillon, M.H.; Burbridge, M.F.; Pierré, A.; Atassi, G. Anticancer Drugs 1997, 8, 276.
96. Pierré, A.; Leonce, S.; Perez, V.; Atassi G. Cancer Chemother. Pharmacol. 1998, 42, 454.
97. Awada, A.; Giacchetti, S.; Gerard, B.; Eftekhary, P.; Lucas, C.; de Valeriola, D.; Poullain, M.G.; Soudon, J.; Dosquet, C.; Brillanceau, M.-H.; Giroux, B.; Marty, M.; Bleiberg, H.; Calvo, F.; Piccart, M. Ann. Oncol. 2002, 13, 1925.
98. Pivot, X.; Awada, A.; Gedouin, D.; Kerger, J.; Rolland, F.; Cupissol, D.; Caponigro, F.; Comella, G.; Lopez-Pousa, J.J.; Guardiola, E.; Giroux, B.; Gérard, B.; Schneider, M. Ann. Oncol. 2003, 14, 373.
99. Le Mée, S.; Pierré, A.; Markovits, J.; Atassi, G.; Jacquemin-Sablon, A.; Saucier, J.M. Mol. Pharmacol. 1998, 53, 213.
100. Le Mée, S.; Chaminade, F.; Delaporte, C.; Markovits, J.; Saucier, J.M.; Jacquemin-Sablon, A. Mol. Pharmacol. 2000, 58, 709.
101. Guilloneau, C.; Pierré, A.; Charton, Y.; Guilbaud, N.; Kraus-Berthier, L.; Leonce, S.; Michel, A.; Bisagni, E.; Atassi, G. J. Med. Chem. 1999, 42, 2191.
102. Kraus-Berthier, L.; Guilbaud, N.; Leonce, S.; Parker, T.; Genissel, P.; Guillonneau, C.; Goldstein, S.; Atassi, G.; Pierré, A. Cancer Chemother. Pharmacol. 2002, 50, 95.
103. Malonne, H.; Farinelle, S.; Decaestecker, C.; Gordower, L.; Fontaine, J.; Chaminade, F.; Saucier, J.M.; Atassi, G.; Kiss, R. Clin. Cancer Res. 2000, 6, 3774.
104. Guillonneau, C.; Nault, A.; Raimbaud, E.; Léonce, S.; Kraus-Berthier, L.; Pierré, A.; Goldstein., S. Bioorg. Med. Chem. 2005, 13, 175.
105. Delepierre, M.; Milhe, C.; Namane, A.; Dinh, T.H.; Roques, B.P. Biopolymers 1991, 31, 331.
106. Gao, Q.; Williams, L.D.; Egli, M.; Rabinovich, D.; Chen, S.L.; Quigley, G.J.; Rich, A. Proc. Natl. Acad. Sci. USA 1991, 88, 2422.
107. Williams, L.D.; Gao, Q. Biochemistry 1992, 31, 4315.
108. Crow, S.D.; Bailly, C.; Garbay-Jaureguiberry, C.; Roques, B; Shaw, B.R.; Waring, M.J. Biochemistry 2002, 41, 8672.
109. Lambert, B.; Roques, B.P.; Le Pecq, J.B. Nucleic Acids Res. 1988, 16, 1063.
110. Lambert, B.; Segal-Bendirdjian, E.; Esnault, C.; Le Pecq, J.B.; Roques, B.P.; Jones, B.; Yeung, A.T. Anti-Cancer Drug Des. 1990, 5, 43.
111. Fellous, R.; Coulaud, D.; el Abed, I.; Roques, B.; Le Pecq, J.B.; Delain, E; Gouyette, A. Cancer Res. 1988, 48, 6542.
112. Carrasco, C.;Rosu, F.; Gabelica, V.; Houssier, C.; De Pauw, E.; Garbay-Jaureguiberry, C.; Roques, B.P.; Wilson, W.D.; Chaires, J.B.; Waring, M.J.; Bailly, C. Chembiochem 2002, 3, 1235.
113. Leteurtre, F.; Madalengoitia, J.; Orr, A.; Guzi, T.J.; Lehnert, E.; Macdonald, T.; Pommier, Y. Cancer Res. 1992, 52, 4478.
114. Leteurtre, F.; Sackett, D.L.; Madalengoitia, J.; Kohlhagen, G.; Macdonald, T.; Hamel, E.; Paull, K.D.; Pommier, Y. Biochem. Pharmacol. 1995, 49, 1283.
115. Madalengoitia, J.S.; Tepe, J.J.; Wrbovetz, K.A.; Lehnert, E.K.; Macdonald, T.L. Bioorg. Med. Chem. 1997, 5, 1807.
116. Miller, T.A.; Vachaspati, P.R.; Labroli, M.A.; Thompson, C.D.; Butman, A.L.; Macdonald, T.L. Bioorg. Med. Chem. Lett. 1998, 8, 1065.
117. Tepe, J.J.; Madalengoitia, J.S.; Slunt, K.M.; Werbovetz, K.W.; Spoors, P.G.; Macdonald, T.L. J. Med. Chem. 1996, 39, 2188.
118. Cline, S.D.; Macdonald, T.L.; Osheroff, N. Biochemisty 1997, 36, 13095.
119. Solary, E.; Leteurtre, F.; Paull, K.D.; Scudiero, D.; Hamel; E.; Pommier, Y. Biochem. Pharmacol. 1993, 45, 2449.
120. Bailly, C.; Leclere, V.; Pommery, N.; Colson, P.; Houssier, C.; Rivalle, C.; Bisagni, E.; Henichart, J.P. Anticancer Drug Des. 1993, 8, 145.
121. Bailly, C.; Michaux, C.; Colson, P.; Houssier, C.; Sun, J.S.; Garestier, T.; Helene, C.; Henichart, J.P.; Rivalle, C.; Bisagni, E. Biochemistry 1994, 33, 15348.
122. Riou, J.F.; Grondard, L.; Naudin, A.; Bailly, C. Biochem. Pharmacol. 1995, 50, 424.
123. Devraj, R.; Barrett, J.F.; Fernandez, J.A.; Katzenellenbogen, J.A.; Cushman, M. J. Med. Chem. 1996, 39, 3367.
124. Moinet-Hedin, V.; Tabka, T.; Sichel, F.; Gauduchon, P.; Le Talaër, J.Y.; Saturnino, C.; Letois, B.; Lancelot, J.C.; Robba, M. Eur. J. Med. Chem. 1997, 32, 113.
125. Saturnino, C.; Buonerba, M.; Boatto, G.; Pascale, M.; Moltedo, O.; De Napoli, L.; Montesarchio, D.; Lancelot, J.-C.; de Capraris, P. Chem. Pharm. Bull. 2003, 51, 971.
126. Moody, T.W.; Czerwinski, G.; Tarasova, N.I.; Michejda, C.J. Life Sci. 2002, 71, 1005.
127. Moody, T.W.; Czerwinski, G.; Tarasova, N.I.; Moody, D.L.; Michejda, C.J. Regulatory Peptides 2004, 123, 187.
128. Asche, C.; Frank, W.; Albert, A.; Kucklaender, U. Bioorg. Med. Chem. 2005, 13, 819.
129. von Angerer, E.; Prekajac, J. J. Med. Chem. 1983, 26, 113.
130. von Angerer, E.; Prekajac, J.; Berger, M. Eur. J. Cancer Clin. Oncol. 1985, 21, 531.
131. von Angerer, E.; Prekajac, J. J. Med. Chem. 1985, 29, 380.
132. Leichtl, S.; von Angerer, E. Arch. Pharm. Pharm. Med. Chem. 1998, 331, 283.
133. Golob, T.; Biberger, C.; Walter, G.; von Angerer, E. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 305.
134. Segall, A.; Pappa, H.; Casaubon, R.; Martin, G.; Bergoc, R.; Pizzorno, M.T. Eur. J. Med. Chem. 1995, 30, 165.
135. Segall, A.; Pizzorno, M.T. Pharmazie 2000, 55, 766.
136. Martin, G.; Cocca, C.; Rivera, E.; Cricco, G.; Caro, R.; Segall, A.; Pappa, H.; Casaubon, R.; Pizzomo, M.T.; Bergoc, R.M. J. Exp. Ther. Oncol. 2002, 2, 77.
137. Laronze, M.; Boisbrun, M.; Léonce, S.; Pfeiffer, B.; Renard, P.; Lozach, O.; Meijer, L.; Lansiaux, A.; Bailly, C.; Sapi, J.; Laronze, J.-Y. Bioorg. Med. Chem. 2005, 13, 2263.
138. Joseph, B.; Facompré, M.; Da Costa, H.; Routier, S.; Mérour, J.-Y.; Colson, P.; Houssier, C.; Bailly, C. Bioorg. Med. Chem. 2001, 9, 1533.
139. Tran-Thi, H.; Nguyen-Thi, T.; Michel, S.; Tillequin, F.; Koch M.; Pfeiffer, B.; Pierre, B.; Trinh-Van-Dufat, H. Chem. Pharm. Bull. 2004, 52, 540.
140. Borowitzka, M.A. J. Appl. Phycol. 1995, 7, 3.
141. Smith, G.D.; Doan, N.T. J. Appl. Phycol. 1999, 11, 337.
142. Rickards, R.W.; Rothschild, J.W.; Willis, A.C.; de Chazal, N.M.; Kirk, J.; Kirk, K.; Saliba, K.J.; Smith, G.D. Tetrahedron 1999, 55, 13513.
143. Bernardo, P.H.; Chai, C.L.; Heath, G.A.; Mahon, P.J.; Smith, G.D.; Waring, P.; Wilkes, B.A. J. Med. Chem. 2004, 47, 4958.
144. Grafe-Christphe, S.; Kuehm-Caubère, C.; Renard, P.; Pfeiffer, B.; Pierré, A.; Léonce, S.; P. Caubère, P. Bioorg. Med. Chem. Lett. 2000, 10, 2589.
145. Nakamura, K.; Sugumi, H.; Yamaguchi, A.; Uenaka, T.; Kotake, Y.; Okada, T.; Kamata, J.; Niijima, J.; Nagasu, T.; Koyanagi, N.; Yoshino, H.; Kitoh, K.; Yoshimatsu, K. Mol. Cancer Ther. 2002, 1, 169.
146. Nakamura, K.; Uenaka, T.; Nagasu, T.; Sugumi, H.; Yamaguchi, A.; Kotake, Y.; Okada, T.; Kamata, J.; Niijima, J.; Taniguchi, T.; Koyanagi, N.; Yoshino, H.; Kitoh, K.; Yoshimatsu, K. Cancer Sci. 2002, 94, 119.
147. Nakamura, K.; Taniguchi, T.; Funahashi, Y.; Yoshimatsu, K. Mol. Cancer Ther. 2003, 2, 59.
148. Kamata, J.; Okada, T.; Kotake, Y.; Niijima, J.; Nakamura, K.; Uenaka, T.; Yamaguchi, A.; Tsukahara, K.; Nagasu, T; Koyanagi, N.; Kitoh, K.; Yoshimatsu, K.; Yoshino, H.; Sugumi, H. Chem. Pharm. Bull. 2004, 52, 1071.
149. Bailly, C. in "DNA and RNA binders: from small molecules to drugs", vol. 2, (Demeunynck, M., Bailly, C. and Wilson W. D. Eds),. Wiley-VCH Verlag GmbH, Weinheim 2003, pp 538-575.
150. Prudhomme, M. Eur. J. Med. Chem. 2005, 38, 123.
151. Nettleton, D. E.; Doyle, T. W.; Krishnan, B.; Matsumoto, G. K.; Clardy, J. Tetrahedron Lett. 1985, 26, 4011.
152. Lam, K. S.; Schroeder, D. R.; Veitch, J. M.; Colson, K. L.; Matson, J. A.; Rose, W. C.; Doyle, T. W.; Forenza, S. J. Antibiot. 2001, 54, 1.
153. Bailly, C.; Riou, J. F.; Colson, P.; Houssier, C.; Rodrigues-Pereira, E.; Prudhomme, M. Biochemistry, 1997, 36, 3917.
154. Carrasco, C.; Facompré, M.; Chisholm, J. D.; Van Vranken, D. L.; Wilson, W. D.; Bailly, C. Nucleic Acids Res. 2002, 30, 1774.
155. Moreau, P.; Anizon, F.; Sancelme, M.; Prudhomme, M.; Severe, D.; Riou, J. F.; Goosens, J. F.; Henichart, J. P.; Bailly, C.; Labourier, E.; Tazzi, J.; Fabbro, D.; Meyer, T.; Aubertin, A. M. J. Med. Chem. 1999, 42, 1816.
156. Anizon, F.; Belin, L.; Moreau, P.; Sancelme, M.; Voldoire, A.; Prudhomme, M.; Ollier, M.; Severe, D.; Riou, J. F.; Bailly, C.; Fabbro, D.; Meyer, T. J. Med. Chem. 1997, 40, 3456.
157. Moreau, P.; Anizon, F.; Sancelme, M.; Prudhomme, M.; Bailly, C.; Carrasco, C.; Ollier, M.; Severe, D.; Riou, J. F.; Fabbro, D. Meyer, T. Aubertin, A. M. J. Med. Chem. 1998, 41, 1631.
158. Gilbert, E. J.; Chisholm, J. D.; Van Vranken, D. L. J. Org. Chem. 1999, 64, 5670.
159. Kojiri, K.; Kondo, H.; Yoshinari, T.; Arakawa, H.; Nakajima, S.; Satoh, F.; Kawamura, K.; Okura, A.; Suda, H.; Okanishi, M. J. Antibiot. 1991, 44, 723.
160. Yoshinari, T.; Matsumoto, M.; Arakawa, H.; Okada, H.; Noguchi, K.; Suda, H.; Okura, A.; Nishimura, S. Cancer Res. 1995, 55, 1310.
161. Carrasco, C.; Vezin, H.; Wilson, W. D.; Ren, J. Chaires, J. B.; Bailly, C. Anti-Cancer Drug Des. 2002, 16, 99.
162. Facompré, M.; Goosens, J. F.; Bailly, C. Biochem. Pharmacol. 2001, 61, 299.
163. Sasaki, Y.; Tanigawara, Y.; Fujii, H.; Ohtsu, T.; Wakata, H.; Igarashi, T.; Itoh, K.; Ogino, H.; Takenaga, N.; Okada, K. Proc. ASCO 1995, 14, abstract number 373.
164. Ohe, Y.; Tanigawara, Y.; Fujii, H.;Ohtsu, T.; Wakita, H.; Igarashi, T.; Minami, H.; Eguchi, K.; Shinkai, T.; Tamura, T.; Kunitoh, H. Saijo, N.; Okada, K.; Ogino, H.; Sasaki, Y. Proc. ASCO 1997, abstract number 700.
165. Arakawa, H.; Morita, M.; Kodera, T.; Okura, A.; Ohkubo, M.; Morishima, H.; Nishimura, S. Jpn. J. Cancer Res. 1999, 90, 1163.
166. Cavazos, C. M.; Keir, S. T.; Yoshinari, T.; Bigner, D. D.; Friedman, H. S. Cancer Chemother. Pharmacol. 2001, 48, 250.
167. Yamada, Y.; Tamura, T.; Yamamoto, N.; Shimoyama, T.; Ueda, Y.; Murakami, H.; Kusaba, H.; Kamiya Y.; Saka, H.; Tanigawara, Y.; McGovren, J. P.; Natsumeda, Y. Cancer Chemother. Pharmacol. 2006, 58, 173.
168. Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.; Tomita, F. Biochem. Biophys. Res. Commun. 1986, 131, 442.
169. Ruegg, U. T.; Burgess, G. M. Trends Pharmacol. Sci. 1989, 10, 218.
170. Prudhomme, M. Curr. Med. Chem.- Anticancer Agents 2004, 4, 509.
171. Akinaga, S.; Sugiyama, K.; Akiyama, T. Anticancer Drug Des. 2000, 15, 43.
172. Fuse, E.; Tanii, H.; Kurata, N.; Kobayashi, H.; Shimada, Y.; Tamura, T.; Sasaki, Y.; Tanigawara, Y.; Lush, R. D.; Headlee, D. Figg, W. D.; Arbuck, S. G.; Senderowicz, A. M.; Sausville, E. A.; Akinaga, S.; Kuwabara, T.; Kobayashi, S. Cancer Res. 1998, 58, 3248.
173. Hotte, S. J.; Oza, A.; Winquist, E. W.; Moore, M.; Chen, E. X.; Brown, S.; Pond, G. R.; Dancey, J. E.; Hirte, H. W. Ann. Oncol. 2006, 17, 334.
174. Kase, H.; Iwahashi, K.; Matsuda, Y. J. Antibiotics 1986, 39, 1059.
175. Kase, H.; Iwahashi, K.; Nakanishi, S; Matsuda, Y.; Yamada, K.; Takahashi, M.; Murakata, C.; Sato, A. Kaneko, M. Biochem. Biophys. Res. Commun. 1987, 142, 436.
176. Miknyoczki, S. J.; Chang, H.; Klein-Szanto, A.; Dionne, C. A.; Ruggeri, B. A. Clin. Cancer Res. 1999, 5, 2205.
177. George, D. J.; Dionne, C. A.; Jani, J.; Angeles, T.; Murakata, C.; Lamb, J.; Isaacs, J. T. Cancer Res. 1999, 59, 2395.
178. Yamashita, Y.; Fujii, N.; Murakata, C.; Ashizawa, T.; Okabe, M.; Nakano, H. Biochemistry, 1992, 31, 12069.